For the past couple of years, cannabidiol (“CBD”) has held the world’s attention. Extracted from industrial hemp, a nonpsychoactive variety of cannabis, CBD is brimming with potent medicinal properties. Anecdotal evidence and preliminary research have found it effective against a host of medical conditions including anxiety, insomnia, post-traumatic stress disorder (“PTSD”) and pain.
According to a team of researchers from Italy and the United States, cannabidiol may also offer relief against scalp inflammation. Also known as scalp dermatitis, inflammation of the scalp usually results in flaky, itchy and painful patches. It is often caused by scalp psoriasis and seborrheic dermatitis. Dr. Shani Francis, a board-certified dermatologist who specializes in hair loss and the chief wellness…
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.